pubblicazioni scientifiche su COVID-19
pubblicazioni
Pubblicazioni
Scientifiche
Indicazioni e pubblicazioni scientifiche su COVID-19
Su questa pagina è possibile visualizzare le pubblicazioni scientifiche sul COVID-19 elencate.
Suggeriamo inoltre la consultazione della pagina LINK A SITI ISTITUZIONALI, dove si trovano aggiornamenti sulla pandemia da COVID-19, e di DOCUMENTI SIF SU COVID-19 dove si possono trovare le schede informative sui farmaci e sulle terapie utilizzate nei pazienti affetti da COVID-19
Pubblicazioni scientifiche
-
9 marzo 2021Acute Allergic Reactions to mRNA COVID-19 Vaccines
-
8 marzo 2021Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19A - Randomized Clinical Trial
-
8 marzo 2021Approaches for Optimal Use of Different COVID-19 Vaccines - Issues of Viral Variants and Vaccine Efficacy
-
2 marzo 2021Binding and Neutralization Antibody Titers After a Single Vaccine Dose in Health Care Workers Previously Infected With SARS-CoV-2
-
2 marzo 2021The Johnson & Johnson Vaccine for COVID-19
-
1 marzo 2021Association of Convalescent Plasma Treatment With Clinical Outcomes in Patients With COVID-19A Systematic Review and Meta-analysis
-
1 marzo 2021Pregnant People’s Paradox—Excluded From Vaccine Trials Despite Having a Higher Risk of COVID-19 Complications
-
1 marzo 2021SARS-CoV-2 Vaccines
-
22 febbraio 2021High-Income Countries Have Secured the Bulk of COVID-19 Vaccines
-
22 febbraio 2021Follow-up Survey of US Adult Reports of Mental Health, Substance Use, and Suicidal Ideation During the COVID-19 Pandemic, September 2020
-
22 febbraio 2021Taking Vaccine to Where the Virus Is—Equity and Effectiveness in Coronavirus Vaccinations
-
22 febbraio 2021Medicaid and COVID-19 Vaccination—Translating Equitable Allocation Into Equitable Administration
-
22 febbraio 2021CDC Studies Underscore Continued Importance of Masks to Prevent Coronavirus Spread
-
22 febbraio 2021The US Regulatory System and COVID-19 Vaccines - The Importance of a Strong and Capable FDA
-
19 febbraio 2021The Price of Success—How to Evaluate COVID-19 Vaccines When They’re Available Outside of Clinical Trials
-
18 febbraio 2021Vitamin D3 to Treat COVID-19 - Different Disease, Same Answer
-
18 febbraio 2021Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19A - Randomized Clinical Trial
-
15 febbraio 2021Reports of Anaphylaxis After Receipt of mRNA COVID-19 Vaccines in the US—December 14, 2020-January 18, 2021
-
12 febbraio 2021SARS-CoV-2 Viral Variants—Tackling a Moving Target
-
12 febbraio 2021Assessment of Outpatient Dispensing of Products Proposed for Treatment or Prevention of COVID-19 by US Retail Pharmacies During the Pandemic
-
11 febbraio 2021Effectiveness of Mask Wearing to Control Community Spread of SARS-CoV-2
-
11 febbraio 2021Involving Pregnant Individuals in Clinical Research on COVID-19 Vaccines
-
9 febbraio 2021COVID-19 Vaccination in Pregnant and Lactating Women
-
9 febbraio 2021Pregnancy, Postpartum Care, and COVID-19 Vaccination in 2021
-
9 febbraio 2021Protecting Pregnant Women and Their Infants From COVID-19: Clues From Maternal Viral Loads, Antibody Responses, and Placentas
-
9 febbraio 2021Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin
-
8 febbraio 2021Povidone Iodine Mouthwash, Gargle, and Nasal Spray to Reduce Nasopharyngeal Viral Load in Patients With COVID-19A Randomized Clinical Trial
-
3 febbraio 2021SARS-CoV-2 Vaccines and the Growing Threat of Viral Variants
-
25 gennaio 2021Change in Reported Adherence to Nonpharmaceutical Interventions During the COVID-19 Pandemic, April-November 2020
-
25 gennaio 2021Effect of Discontinuing vs Continuing Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers on Days Alive and Out of the Hospital in Patients Admitted With COVID-19 - A Randomized Clinical Trial
-
22 gennaio 2021Allergic Reactions Including Anaphylaxis After Receipt of the First Dose of Pfizer-BioNTech COVID-19 Vaccine
-
22 gennaio 2021Effect of Bamlanivimab as Monotherapy or in Combination With Etesevimab on Viral Load in Patients With Mild to Moderate COVID-19A Randomized Clinical Trial
-
22 gennaio 2021Neutralizing Monoclonal Antibody for Mild to Moderate COVID-19
-
18 gennaio 2021Funding of Pharmaceutical Innovation During and After the COVID-19 Pandemic
-
14 gennaio 2021Modernize Medical Licensing, and Credentialing, Too—Lessons From the COVID-19 Pandemic
-
14 gennaio 2021The COVID-19 Pandemic—An Opportune Time to Update Medical Licensing
-
4 gennaio 2021The Hidden Epidemic of Opioid Overdoses During the Coronavirus Disease 2019 Pandemic
-
30 dicembre 2020Internet Searches for Unproven COVID-19 Therapies in the United States
-
30 dicembre 2020Building Trust to Achieve Confidence in COVID-19 Vaccines
-
30 dicembre 2020Mandating COVID-19 Vaccines
-
30 dicembre 2020Reassuring the Public and Clinical Community About the Scientific Review and Approval of a COVID-19 Vaccine
-
30 dicembre 2020National Trends in the US Public’s Likelihood of Getting a COVID-19 Vaccine—April 1 to December 8, 2020
-
28 dicembre 2020Pathophysiology, Transmission, Diagnosis, and Treatment of Coronavirus Disease 2019 (COVID-19) - A Review
-
28 dicembre 2020Mask Exemptions During the COVID-19 Pandemic—A New Frontier for Clinicians
-
28 dicembre 2020Association of Vitamin D Status and Other Clinical Characteristics With COVID-19 Test Results
-
22 dicembre 2020Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic
-
21 dicembre 2020The Risks of Prescribing Hydroxychloroquine for Treatment of COVID-19—First, Do No Harm
-
21 dicembre 2020Treatment of Opioid Use Disorder Among Commercially Insured Patients in the Context of the COVID-19 Pandemic
-
21 dicembre 2020Changes in Outpatient Buprenorphine Dispensing During the COVID-19 Pandemic
-
21 dicembre 2020Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program
-
21 dicembre 2020Evaluating SARS-CoV-2 Vaccines After Emergency Use Authorization or Licensing of Initial Candidate Vaccines
-
15 dicembre 2020The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials
-
11 dicembre 2020Evaluation of Cloth Masks and Modified Procedure Masks as Personal Protective Equipment for the Public During the COVID-19 Pandemic
-
11 dicembre 2020Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine
-
11 dicembre 2020Filtration Efficiency of Face Masks Used by the Public During the COVID-19 Pandemic
-
9 dicembre 2020Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
-
9 dicembre 2020Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets
-
2 dicembre 2020Diagnosis, Management, and Pathophysiology of Arterial and Venous Thrombosis in COVID-19
-
1 dicembre 2020The Colchicine Debacle Revisited
-
30 novembre 2020Antibodies, Immunity, and COVID-19
-
30 novembre 2020Study Aims to Identify Drugs That Could Be Repurposed for COVID-19
-
30 novembre 2020Clinical, Laboratory, and Interferon-Alpha Response Characteristics of Patients With Chilblain-like Lesions During the COVID-19 Pandemic
-
16 novembre 2020Therapy for Early COVID-19A Critical Need
-
16 novembre 2020SARS-CoV-2 Neutralizing Antibody LY-CoV555 in Outpatients with Covid-19
-
16 novembre 2020Fluvoxamine vs Placebo and Clinical Deterioration in Outpatients With Symptomatic COVID-19 - A Randomized Clinical Trial
-
12 novembre 2020Speed, Evidence, and Safety Characteristics of Vaccine Approvals by the US Food and Drug Administration
-
12 novembre 2020Misguided Use of Hydroxychloroquine for COVID-19 - The Infusion of Politics Into Science
-
12 novembre 2020Effect of Hydroxychloroquine on Clinical Status at 14 Days in Hospitalized Patients With COVID-19 - A Randomized Clinical Trial
-
2 novembre 2020Shifting Hydroxychloroquine Patterns Raise Concern
-
2 novembre 2020Preventing the Spread of SARS-CoV-2 With Masks and Other “Low-tech” Interventions
-
21 ottobre 2020Effect of Tocilizumab vs Usual Care in Adults Hospitalized With COVID-19 and Moderate or Severe Pneumonia - A Randomized Clinical Trial
-
21 ottobre 2020Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19
-
21 ottobre 2020Time to Reassess Tocilizumab’s Role in COVID-19 Pneumonia - Editorial
-
21 ottobre 2020Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia - A Randomized Clinical Trial
-
19 ottobre 2020Postapproval Vaccine Safety Surveillance for COVID-19 Vaccines in the US
-
19 ottobre 2020Answering Key Questions About COVID-19 Vaccines
-
19 ottobre 2020Postlicensure Evaluation of COVID-19 Vaccines
-
19 ottobre 2020Sensible Medicine—Balancing Intervention and Inaction During the COVID-19 Pandemic
-
6 ottobre 2020Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19
-
1 ottobre 2020Efficacy and Safety of Hydroxychloroquine vs Placebo for Pre-exposure SARS-CoV-2 Prophylaxis Among Health Care WorkersA Randomized Clinical Trial
-
30 settembre 2020Analysis of Drug Test Results Before and After the US Declaration of a National Emergency Concerning the COVID-19 Outbreak
-
30 settembre 2020Changes in Lung Cancer Treatment as a Result of the Coronavirus Disease 2019 Pandemic
-
30 settembre 2020The Opioid Epidemic During the COVID-19 Pandemic
-
30 settembre 2020In Vitro Efficacy of a Povidone-Iodine Nasal Antiseptic for Rapid Inactivation of SARS-CoV-2
-
17 settembre 2020Immune Stimulation With Recombinant Human Granulocyte Colony–Stimulating Factor for Coronavirus Disease 2019 (COVID-19)—Beware of Blind Spots
-
17 settembre 2020Effect of Recombinant Human Granulocyte Colony–Stimulating Factor for Patients With Coronavirus Disease 2019 (COVID-19) and Lymphopenia - A Randomized Clinical Trial
-
14 settembre 2020Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19 - The CoDEX Randomized Clinical Trial
-
14 settembre 2020Effect of Hydrocortisone on Mortality and Organ Support in Patients With Severe COVID-19 - The REMAP-CAP COVID-19 Corticosteroid Domain Randomized Clinical Trial
-
14 settembre 2020Corticosteroids in COVID-19 ARDS - Evidence and Hope During the Pandemic
-
14 settembre 2020COVID-19 and mRNA Vaccines — First Large Test for a New Approach
-
14 settembre 2020Emergency Use Authorizations During the COVID-19 Pandemic - Lessons From Hydroxychloroquine for Vaccine Authorization and Approval
-
14 settembre 2020Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19 - A Meta-analysis
-
14 settembre 2020Effect of Hydrocortisone on 21-Day Mortality or Respiratory Support Among Critically Ill Patients With COVID-19 - A Randomized Clinical Trial
-
3 settembre 2020Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Death in Patients Hospitalised with COVID‑19: A Retrospective Italian Cohort Study of 43,000 Patients
-
31 agosto 2020Approaching coronavirus disease 2019: Mechanisms of action of repurposed drugs with potential activity against SARS-CoV-2
-
31 agosto 2020Neutralizing Antibodies Against SARS-CoV-2—Important Questions, Unclear Answers
-
31 agosto 2020Efficacy of Remdesivir in COVID-19
-
31 agosto 2020Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients With Moderate COVID-19A Randomized Clinical Trial
-
31 agosto 2020Effect of an Inactivated Vaccine Against SARS-CoV-2 on Safety and Immunogenicity OutcomesInterim Analysis of 2 Randomized Clinical Trials
-
31 agosto 2020Case Rates, Treatment Approaches, and Outcomes in Acute Myocardial Infarction During the Coronavirus Disease 2019 Pandemic
-
31 agosto 2020Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19
-
31 agosto 2020Rethinking Clinical Trials Reform During the COVID-19 Pandemic
-
3 agosto 2020Weighing the Benefits and Risks of Proliferating Observational Treatment AssessmentsObservational Cacophony, Randomized Harmony
-
3 agosto 2020COVID-19 and DexamethasoneA Potential Strategy to Avoid Steroid-Related Strongyloides Hyperinfection
-
3 agosto 2020Setting Expectations for Clinical Research During the COVID-19 Pandemic
-
3 agosto 2020Characteristics and Strength of Evidence of COVID-19 Studies Registered on
-
20 luglio 2020Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic
-
2 luglio 2020Is a “Cytokine Storm” Relevant to COVID-19?
-
29 giugno 2020Missed Opportunities on Emergency Remdesivir Use
-
29 giugno 2020Effect of Colchicine vs Standard Care on Cardiac and Inflammatory Biomarkers and Clinical Outcomes in Patients Hospitalized With Coronavirus Disease 2019The GRECCO-19 Randomized Clinical Trial
-
29 giugno 2020Colchicine for the Treatment of Myocardial Injury in Patients With Coronavirus Disease 2019 (COVID-19)—An Old Drug With New Life?
-
26 giugno 2020Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
-
26 giugno 2020Monoclonal Antibodies for Prevention and Treatment of COVID-19
-
15 giugno 2020Use of siltuximab in patients with COVID-19 pneumonia requiring ventilatory support
-
15 giugno 2020Effective treatment of severe COVID-19 patients with tocilizumab
-
15 giugno 2020Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial
-
15 giugno 2020JAK Inhibition as a New Treatment Strategy for Patients with COVID-19
-
15 giugno 2020Interleukin-6 blockade for severe COVID-19
-
15 giugno 2020The novel immunomodulatory biologic LMWF5A for pharmacological attenuation of the “cytokine storm” in COVID-19 patients: a hypothesis
-
15 giugno 2020Emerging pharmacotherapies for COVID-19
-
15 giugno 2020Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study
-
15 giugno 2020Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
-
15 giugno 2020Tocilizumab treatment in COVID‐19: A single center experience
-
9 giugno 2020Risk of Hospitalization With Hemorrhage Among Older Adults Taking Clarithromycin vs Azithromycin and Direct Oral Anticoagulants
-
8 giugno 2020Effect of Convalescent Plasma Therapy on Time to Clinical Improvement in Patients With Severe and Life-threatening COVID-19A Randomized Clinical Trial
-
8 giugno 2020Correlation Between N95 Extended Use and Reuse and Fit Failure in an Emergency Department
-
8 giugno 2020Outpatient Treatment at Home for Medicare Beneficiaries During and After the COVID-19 Pandemic
-
8 giugno 2020Coronavirus Disease 2019 and Opioid Use—A Pandemic Within an Epidemic
-
8 giugno 2020Early Intervention of Palliative Care in the Emergency Department During the COVID-19 Pandemic
-
8 giugno 2020Simulated Assessment of Pharmacokinetically Guided Dosing for Investigational Treatments of Pediatric Patients With Coronavirus Disease 2019
-
8 giugno 2020How to Rapidly Determine First-in-Children Dosing for COVID-19 Therapeutics
-
8 giugno 2020Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
-
5 giugno 2020Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence
-
5 giugno 2020Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
-
5 giugno 2020Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an openlabel non-randomized clinical trial
-
5 giugno 2020Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
-
5 giugno 2020Pharmacotherapy in COVID-19; A Narrative Review for Emergency Providers
-
5 giugno 2020COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
-
5 giugno 2020COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome?
-
5 giugno 2020The FDA-approved gold drug auranofin inhibits novel coronavirus (SARSCOV- 2) replication and attenuates inflammation in human cells
-
5 giugno 2020COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country
-
5 giugno 2020The use of anti-inflammatory drugs in the treatment of people with severe coronavirus disease 2019 (COVID-19): The Perspectives of clinical immunologists from China
-
5 giugno 2020Treatment options for COVID-19: The reality and challenges
-
5 giugno 2020The pathogenesis and treatment of the ‘Cytokine Storm’ in COVID-19
-
5 giugno 2020COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs
-
5 giugno 2020COVID-19: Melatonin as a potential adjuvant treatment
-
5 giugno 2020A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
-
4 giugno 2020COVID-19: combining antiviral and anti-inflammatory treatments
-
4 giugno 2020Anti‑IL6R role in treatment of COVID‑19‑related ARDS
-
4 giugno 2020Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases
-
4 giugno 2020Anti-inflammatory effects of macrolides—an underappreciated benefit in the treatment of community-acquired respiratory tract infections and chronic inflammatory pulmonary conditions?
-
4 giugno 2020Is there a Role for Inhaled Corticosteroids and Macrolide Therapy in Bronchiectasis?
-
1 giugno 2020Using Controlled Trials to Resolve Key Unknowns About Policy During the COVID-19 Pandemic
-
1 giugno 2020Conducting Clinical Research During the COVID-19 PandemicProtecting Scientific Integrity
-
1 giugno 2020Adverse Consequences of Rushing a SARS-CoV-2 VaccineImplications for Public Trust
-
1 giugno 2020Coronavirus Disease 2019 and Opioid Use—A Pandemic Within an Epidemic
-
1 giugno 2020Assessment of the Qualitative Fit Test and Quantitative Single-Pass Filtration Efficiency of Disposable N95 Masks Following Gamma Irradiation
-
1 giugno 2020Weight-Based Dosing of Pembrolizumab Every 6 Weeks in the Time of COVID-19
-
1 giugno 2020Prescription Fill Patterns for Commonly Used Drugs During the COVID-19 Pandemic in the United States
-
29 maggio 2020Efficacy and safety of lopinavir/ritonavir or arbidol in adult patients with mild/moderate COVID-19: an exploratory randomized controlled trial
-
29 maggio 2020Deubiquitinating Enzymes in Coronaviruses and Possible Therapeutic Opportunities for COVID-19
-
26 maggio 2020Planning for a COVID-19 Vaccination Program
-
26 maggio 2020Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies
-
26 maggio 2020Coronavirus Disease 2019 (COVID-19) and Immune-Engaging Cancer Treatment
-
26 maggio 2020Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)An Unprecedented Partnership for Unprecedented Times
-
20 maggio 2020Traditional Chinese medicine for treatment of coronavirus disease 2019: a review
-
20 maggio 2020Need for Transparency and Reliable Evidence in Emergency Use Authorizations for Coronavirus Disease 2019 (COVID-19) Therapies
-
18 maggio 2020Association of Treatment With Hydroxychloroquine or Azithromycin With In-Hospital Mortality in Patients With COVID-19 in New York State
-
18 maggio 2020Emergency Use Authorization of RemdesivirThe Need for a Transparent Distribution Process
-
18 maggio 2020SARS-CoV-2 Rates in BCG-Vaccinated and Unvaccinated Young Adults
-
12 maggio 202025-Hydroxyvitamin D Concentrations Are Lower in Patients with Positive PCR for SARS-CoV-2
-
11 maggio 2020Randomized Clinical Trials and COVID-19Managing Expectations
-
11 maggio 2020Association of Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Testing Positive for Coronavirus Disease 2019 (COVID-19)
-
11 maggio 2020Understanding Observational Treatment Comparisons in the Setting of Coronavirus Disease 2019 (COVID-19)
-
11 maggio 2020Palliative Care for Patients With Cancer in the COVID-19 Era
-
11 maggio 2020Cancer and Coronavirus Disease 2019 (COVID-19)—Facing the “C Words”
-
11 maggio 2020The Equitable Distribution of COVID-19 Therapeutics and Vaccines
-
5 maggio 2020A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
-
5 maggio 2020Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19
-
4 maggio 2020Risk of QT Interval Prolongation Associated With Use of Hydroxychloroquine With or Without Concomitant Azithromycin Among Hospitalized Patients Testing Positive for Coronavirus Disease 2019 (COVID-19)
-
4 maggio 2020Assessment of QT Intervals in a Case Series of Patients With Coronavirus Disease 2019 (COVID-19) Infection Treated With Hydroxychloroquine Alone or in Combination With Azithromycin in an Intensive Care Unit
-
30 aprile 2020Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
-
30 aprile 2020The race for coronavirus vaccines: a graphical guide
-
29 aprile 2020Antibody responses to SARS-CoV-2 in patients with COVID-19
-
27 aprile 2020Structure-based design of antiviral drug candidates targeting the SARS-CoV-2 main protease
-
27 aprile 2020L’EMA richiama l’attenzione sul rischio di gravi effetti indesiderati con clorochina e idrossiclorochina. AIFA 23 aprile 2020
-
27 aprile 2020Segnalazione di sospette reazioni avverse ai medicinali nei pazienti con COVID-19. AIFA 21 aprile 2020
-
27 aprile 2020Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
-
27 aprile 2020Effect of the COVID-19 pandemic on cancer treatment and research
-
27 aprile 2020A real-time dashboard of clinical trials for COVID-19
-
27 aprile 2020Probiotics and COVID-19: one size does not fit all
-
27 aprile 2020Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19
-
27 aprile 2020Compassionate Use of Remdesivir for Patients with Severe Covid-19
-
27 aprile 2020Incidence of Adverse Drug Reactions in COVID‐19 patients in China: an active monitoring study by Hospital Pharmacovigilance System
-
27 aprile 2020Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection in Children and Adolescents - A Systematic Review
-
27 aprile 2020Association of Renin-Angiotensin System Inhibitors With Severity or Risk of Death in Patients With Hypertension Hospitalized for Coronavirus Disease 2019 (COVID-19) Infection in Wuhan, China
-
27 aprile 2020Caution Needed on the Use of Chloroquine and Hydroxychloroquine for Coronavirus Disease 2019
-
27 aprile 2020Effect of High vs Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection - A Randomized Clinical Trial
-
27 aprile 2020Management of COVID-19 Respiratory Distress
-
23 aprile 2020Manuale COVID-19 - AIMS
-
21 aprile 2020Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
-
20 aprile 2020Meeting the Care Needs of Older Adults Isolated at Home During the COVID-19 Pandemic
-
20 aprile 2020Finding Effective Treatments for COVID-19 - Scientific Integrity and Public Confidence in a Time of Crisis
-
20 aprile 2020Potential Shortages of Hydroxychloroquine for Patients with Lupus During the Coronavirus Disease 2019 Pandemic
-
16 aprile 2020Temporal dynamics in viral shedding and transmissibility of COVID-19
-
16 aprile 2020Emerging SARS-CoV-2 mutation hot spots include a novel RNA-dependent-RNA polymerase variant
-
16 aprile 2020Covid-19: WHO and South Korea investigate reconfirmed cases
-
15 aprile 2020Treatment of COVID-19: old tricks for new challenges
-
15 aprile 2020Structure of Mpro from COVID-19 virus and discovery of its inhibitors
-
15 aprile 2020Breakthrough: Chloroquine phosphate has shown apparent efficacy in treatment of COVID-19 associated pneumonia in clinical studies
-
15 aprile 2020Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period
-
15 aprile 2020Case of the Index Patient Who Caused Tertiary Transmission of Coronavirus Disease 2019 in Korea: the Application of Lopinavir/Ritonavir for the Treatment of COVID-19 Pneumonia Monitored by Quantitative RT-PCR
-
14 aprile 2020Official statement of the section of Clinical Pharmacology of the Italian Society of Pharmacology on the use of ACE- inhibitors or angiotensin receptor blockers in COVID-19 infection with commentary
-
14 aprile 2020Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19)
-
14 aprile 2020Official Statement of the section of Clinical Pharmacology of Italian Society of Pharmacology on Non-steroidal anti-inflammatory drugs (NSAIDs) and the increased risk of complications during infections with commentary
-
1 aprile 2020Link ai lavori su COVID-19 pubblicati su JAMA
JAMA
-
31 marzo 2020Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know
AnnIntMed
-
27 marzo 2020Misguided drug advice for COVID-19
Science
-
27 marzo 2020Coronavirus: la letalità in Italia tra apparenza e realtà
ItalInstPolicStud
-
27 marzo 2020Antihypertensive drugs and risk of COVID-19?
The Lancet
-
23 marzo 2020Critical Care Utilization for the COVID-19 Outbreak in Lombardy, Italy
JAMA
-
18 marzo 2020A Trial of Lopinavir Ritonavir in Adults Hospitalized with Severe Covid-19
NEJM
-
17 marzo 2020A Coronavirus: three things all governments and their science advisers must do now
Nature
-
13 marzo 2020Care for Critically Ill Patients With COVID-19
JAMA
-
4 marzo 2020Angiotensin receptor blockers as tentative SARS-CoV-2 therapeutics
Drug Develo. Res
-
25 febbraio 2020Understanding of COVID‐19 based on current evidence
JMedVirol
-
19 febbraio 2020Breakthrough: Chloroquine Phosphate Has Shown Apparent Efficacy in Treatment of COVID-19 Associated Pneumonia in Clinical Studies
BioSciTrends
-
13 marzo 2003Coronavirus Main Proteinase (3CLpro) Structure: Basis for Design of Anti-SARS Drugs
Science
DISCLAIMER
Il contenuto di questo sito è da intendersi come a scopo puramente informativo.
La Società Italiana di Farmacologia (SIF) non accetta alcuna responsabilità riguardo a possibili errori,
dimenticanze o cattive interpretazioni presenti in queste pagine o in quelle cui si fa riferimento (link).